📣 VC round data is live. Check it out!
- Public Comps
- Hapvida
Hapvida Valuation Multiples
Discover revenue and EBITDA valuation multiples for Hapvida and similar public comparables like Anadolu Sigorta, UFG Insurance, IDI Insurance, ADNIC and more.
Hapvida Overview
About Hapvida
Hapvida Participacoes Investimento SA is the medical-hospital and dental care company. The company and its subsidiaries are mainly engaged in the sale of health insurance plans and delivering the majority of medical assistance at its own hospitals, clinics, imaging diagnostics and laboratories; and the sale of dental insurance plans for services provided by an accredited network.
Founded
1979
HQ

Employees
74.4K
Website
Financials (LTM)
EV
$3B
Valuation Multiples
Start free trialHapvida Financials
Hapvida reported last 12-month revenue of $6B and EBITDA of $573M.
In the same LTM period, Hapvida generated $1B in gross profit, $573M in EBITDA, and had net loss of ($53M).
Revenue (LTM)
Hapvida P&L
In the most recent fiscal year, Hapvida reported revenue of $6B and EBITDA of $802M.
Hapvida is unprofitable as of last fiscal year, with gross margin of 12%, EBITDA margin of 13%, and net margin of (0%).
Financial data powered by Morningstar, Inc.
Hapvida Stock Performance
Hapvida has current market cap of $1B, and enterprise value of $3B.
Market Cap Evolution
Hapvida's stock price is $2.50.
Hapvida share price increased by 1.2% in the last 30 days, and decreased by 69.8% in the last year.
Hapvida has an EPS (earnings per share) of $-0.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $1B | 0.9% | 1.2% | 18.9% | -69.8% | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHapvida Valuation Multiples
Hapvida trades at 0.4x EV/Revenue multiple, and 4.7x EV/EBITDA.
EV / Revenue (LTM)
Hapvida Financial Valuation Multiples
As of May 29, 2026, Hapvida has market cap of $1B and EV of $3B.
Hapvida has a P/E ratio of (22.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hapvida Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Hapvida Margins & Growth Rates
Hapvida grew revenue by 2% but EBITDA decreased by 34% in the last fiscal year.
In the most recent fiscal year, Hapvida reported gross margin of 12%, EBITDA margin of 13%, and net margin of (0%).
Hapvida Margins
Hapvida Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Hapvida Operational KPIs
Hapvida's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Hapvida's Rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hapvida's Rule of X is 14% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Hapvida Competitors
Hapvida competitors include Anadolu Sigorta, UFG Insurance, IDI Insurance, ADNIC, ProAssurance, Saga, Universal Insurance Holdings, Banvida, International General Insurance and Safety Insurance Group.
Most Hapvida public comparables operate across Health Benefits & Financial Solutions, Insurance Carriers and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.3x | 0.2x | - | - | |||
| 0.8x | 0.8x | - | - | |||
| 3.0x | - | - | - | |||
| 0.9x | - | - | - | |||
| 1.6x | 1.8x | - | - | |||
| 1.8x | 1.9x | 9.1x | 9.2x | |||
| 0.3x | 0.3x | - | - | |||
| - | - | 8.8x | - | |||
This data is available for Pro users. Sign up to see all Hapvida competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hapvida
| When was Hapvida founded? | Hapvida was founded in 1979. |
| Where is Hapvida headquartered? | Hapvida is headquartered in Brazil. |
| How many employees does Hapvida have? | As of today, Hapvida has over 74K employees. |
| Who is the CEO of Hapvida? | Hapvida's CEO is Jorge Fontoura Pinheiro Koren de Lima. |
| Is Hapvida publicly listed? | Yes, Hapvida is a public company listed on B3. |
| What is the stock symbol of Hapvida? | Hapvida trades under HAPV3 ticker. |
| When did Hapvida go public? | Hapvida went public in 2018. |
| Who are competitors of Hapvida? | Hapvida main competitors include Anadolu Sigorta, UFG Insurance, IDI Insurance, ADNIC, ProAssurance, Saga, Universal Insurance Holdings, Banvida, International General Insurance, Safety Insurance Group. |
| What is the current market cap of Hapvida? | Hapvida's current market cap is $1B. |
| What is the current revenue of Hapvida? | Hapvida's last 12 months revenue is $6B. |
| What is the current revenue growth of Hapvida? | Hapvida revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Hapvida? | Current revenue multiple of Hapvida is 0.4x. |
| What is the current EBITDA of Hapvida? | Hapvida's last 12 months EBITDA is $573M. |
| What is Hapvida's EBITDA margin? | Hapvida's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Hapvida? | Current EBITDA multiple of Hapvida is 4.7x. |
| What is the current FCF of Hapvida? | Hapvida's last 12 months FCF is $302M. |
| What is Hapvida's FCF margin? | Hapvida's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Hapvida? | Current FCF multiple of Hapvida is 8.9x. |
| How many companies Hapvida has acquired to date? | Hapvida hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Hapvida has invested to date? | Hapvida hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Hapvida
Lists including Hapvida
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.